Demographic disparities in receipt of care at a comprehensive cancer center
Cancer Medicine · 2023
DOI: 10.1002/cam4.5992 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2023. Verfasst von Kedar Kirtane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Healthcare Disparities, Precision Medicine, Cancer Care Facilities. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Division of Cancer Prevention, National Cancer Institute.
Abstract (Originalsprache)
Background
National Cancer Institute cancer centers (NCICCs) provide specialized cancer care including precision oncology and clinical treatment trials. While these centers can offer novel therapeutic options, less is known about when patients access these centers or at what timepoint in their disease course they receive specialized care. This is especially important since precision diagnostics and receipt of the optimal therapy upfront can impact patient outcomes and previous research suggests that access to these centers may vary by demographic characteristics. Here, we examine the timing of patients' presentation at Moffitt Cancer Center (MCC) relative to their initial diagnosis across several demographic characteristics.
Methods
A retrospective cohort study was conducted among patients who presented to MCC with breast, colon, lung, melanoma, and prostate cancers between December 2008 and April 2020. Patient demographic and clinical characteristics were obtained from the Moffitt Cancer Registry. The association between patient characteristics and the timing of patient presentation to MCC relative to the patient's cancer diagnosis was examined using logistic regression.
Results
Black patients (median days = 510) had a longer time between diagnosis and presentation to MCC compared to Whites (median days = 368). Black patients were also more likely to have received their initial cancer care outside of MCC compared to White patients (odds ratio [OR] and 95% confidence interval [CI] = 1.45 [1.32–1.60]). Furthermore, Hispanics were more likely to present to MCC at an advanced stage compared to non‐Hispanic patients (OR [95% CI] = 1.28 [1.05–1.55]).
Conclusions
We observed racial and ethnic differences in timing of receipt of care at MCC. Future studies should aim to identify contributing factors for the development of novel mitigation strategies and assess whether timing differences in referral to an NCICC correlate with long‐term patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
- Office of Community Outreach, Engagement, and Equity, Moffitt Cancer Center, Tampa, Florida, USA.
- Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
- Department of Health Outcomes & Behavior, Moffitt Cancer Center, Tampa, Florida, USA.
ORCID-Profile: Kedar Kirtane, Yayi Zhao, Rossybelle P Amorrortu, Lindsay N Fuzzell, Susan T Vadaparampil, Dana E Rollison
Förderung
- NCI NIH HHS
- Division of Cancer Prevention, National Cancer Institute
Zitieren
APA
Kirtane, K., Zhao, Y., Amorrortu, R. P., Fuzzell, L. N., Vadaparampil, S. T., & Rollison, D. E. (2023). Demographic disparities in receipt of care at a comprehensive cancer center. Cancer Medicine. https://doi.org/10.1002/cam4.5992
Vancouver
Kirtane K, Zhao Y, Amorrortu RP, Fuzzell LN, Vadaparampil ST, Rollison DE. Demographic disparities in receipt of care at a comprehensive cancer center. Cancer Medicine. 2023. doi:10.1002/cam4.5992
BibTeX
@article{Kirtane2023,
author = {Kirtane, Kedar and Zhao, Yayi and Amorrortu, Rossybelle P and Fuzzell, Lindsay N and Vadaparampil, Susan T and Rollison, Dana E},
title = {Demographic disparities in receipt of care at a comprehensive cancer center},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5992}
}
EUVIMED